Venture Capital Investors

GeneChem

GeneChem is a VC firm that helps its portfolio companies by accelerating their success.

Venture Investor Overview

Contact Information

Background Information

Overview

In 2000, based on the initial success of the first GeneChem fund and the changing landscape of the genomics industry, the principals set out to raise their second focused fund, GeneChem Therapeutics Venture Fund L.P.. With committed capital of $136.5 million, the Therapeutics Fund's objectives are to invest within the genomics industry but specifically in companies developing therapeutics for proliferative disorders including cancer, infectious diseases, inflammation and diabetes.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/10/2011

Transaction History

Our records indicate that GeneChem invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

General Partner

Elizabeth Douville

        

General Partner

Inès Holzbaur

        

General Partner

Louis Lacasse

        

General Partner

Martial Lacroix

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

GeneChem has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Genblock Capital | Gener8

Share this article

About Our Venture Capital Investor Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary